Urovo Technology Co., Ltd.

XSEC:300531 Stock Report

Market Cap: CN¥5.0b

Urovo Technology Balance Sheet Health

Financial Health criteria checks 5/6

Urovo Technology has a total shareholder equity of CN¥1.5B and total debt of CN¥582.5M, which brings its debt-to-equity ratio to 38.7%. Its total assets and total liabilities are CN¥2.3B and CN¥827.0M respectively. Urovo Technology's EBIT is CN¥50.2M making its interest coverage ratio -7.3. It has cash and short-term investments of CN¥1.2B.

Key information

38.7%

Debt to equity ratio

CN¥582.53m

Debt

Interest coverage ratio-7.3x
CashCN¥1.17b
EquityCN¥1.51b
Total liabilitiesCN¥827.05m
Total assetsCN¥2.33b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300531's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥795.0M).

Long Term Liabilities: 300531's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥32.1M).


Debt to Equity History and Analysis

Debt Level: 300531 has more cash than its total debt.

Reducing Debt: 300531's debt to equity ratio has increased from 22.9% to 38.7% over the past 5 years.

Debt Coverage: 300531's debt is well covered by operating cash flow (27.9%).

Interest Coverage: 300531 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies